EVENT SUMMARY
The annual PCOC conference hosted by AJMC® brings together leaders in oncology and value-based care to deliver insights into the rapidly changing oncology care landscape. The theme of the 2022 meeting was “Equity Equals Access for All” to help promote the availability of cancer treatments and provide patients with equal access to cancer care. The 2-day annual event provided attendees with the opportunity to interact with knowledgeable experts, hear insights into real-world evidence, precision oncology, clinical pathways, and experience networking opportunities.
PCOC 2022 BY THE NUMBERS
The following titles were accurate as of the PCOC 2022 event but may have changed since then.
40
Faculty
55
Institutions Represented Among Faculty
9
Multidisciplinary Panel Discussions
1
Featured Speaker Session
12
Articles & Videos Produced by AJMC®
1
Publication Produced by AJMC®
Joseph Alvarnas, MD
Joseph Alvarnas, MD

CO-CHAIR, Vice President of Government Affairs and Senior Medical Director for Employer Strategy Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation City of Hope Duarte, CA

Kashyap Patel, MD
Kashyap Patel, MD

CO-CHAIR, CEO, Carolina Blood and Cancer Care Associates ; President , Community Oncology Alliance, Rock Hill, SC

Michael Diaz, MD
Michael Diaz, MD

STEERING COMMITTEE, President and Managing Physician, Florida Cancer Specialists, Tampa, FL

Bruce A Feinberg, DO
Bruce A Feinberg, DO

STEERING COMMITTEE, Vice President, CMO, Cardinal Health Specialty Solutions, Alberta, GA

Ryan Haumschild, PharmD, MS, MBA
Ryan Haumschild, PharmD, MS, MBA

STEERING COMMITTEE, Director of Pharmacy, Winship Cancer Institute at Emory University, Atlanta, GA

Terrill Jordan, LLM, JD
Terrill Jordan, LLM, JD

STEERING COMMITTEE, President & CEO, Regional Cancer Care Associates, Hackensack, NJ

Debra Patt, MD,Ph D,MBA
Debra Patt, MD,Ph D,MBA

STEERING COMMITTEE, Executive Vice President, Texas Oncology, Austin, TX

Jeffrey Patton, MD
Jeffrey Patton, MD

STEERING COMMITTEE, CEO, OneOncology Tennessee Oncology, Nashville, TN

Alyssa Schatz, MSW
Alyssa Schatz, MSW

FEATURED SPEAKER, Senior Director, Policy and Advocacy, National Comprehensive Cancer Network, Plymouth Meeting, PA

ATTENDEES REPRESENT LEADING INSTITUTIONS IN VALUE-BASED ONCOLOGY CARE
  • Activate Health
  • Affiliated Oncologists
  • Agilix Health
  • AllianceRx Walgreens Pharmacy
  • AON Pharmacy
  • Ascension Saint Thomas
  • Atlantic Health System
  • Blue Shield of California
  • Brigham and Women’s Hospital
  • Cancer Center Business Summit
  • Cardinal Health
  • Christine Bates
  • Concierge Hydration
  • Deep Risk Management LLC
  • DKPierce
  • Enlace Health
  • Florida Cancer Specialists
  • GE Healthcare
  • Guideway Care
  • Harvard Medical School
  • Johns Hopkins
  • Kulud pharmacy
  • Labcorp
  • Magellan RX Management
  • McKesson
  • Meijer Specialty Pharmacy
  • Mitsui & Co
  • Nova Southeastern University College of Pharmacy
  • One Oncology
  • Ontada / Mckesson
  • Oregon Health & Science University, Knight Cancer Institute
  • Patient Advocate / Radiation Therapist
  • Patient Discovery Solutions
  • PatientFocus
  • Penn State University
  • Pokhara University Teaching Hospital
  • Premier
  • President Elect Oncology Nursing Society
  • ReVital Cancer Rehabilitation
  • Sharp HealthCare
  • Shields Health Solutions
  • Stealth Startup
  • SUNY Downstate
  • SUNY Upstate Medical University
  • Tennessee Oncology
  • Texas Oncology
  • The US Oncology Network
  • Thyme Care
  • Transcarent
  • Unitedhealthcare
  • University Cancer and Blood Center
  • Vanderbilt University Medical Center
  • West Cancer Center
  • WHEELHOUSE
  • WVSUMC – Cancer Institute
WHAT YOUR COLLEAGUES ARE READING ON AJMC.COM
Explore the most sought-after PCOC coverage

Panel Addresses How Payers, Providers Can Optimally Use Real-World Evidence to Advance Cancer Care

Guideline-Directed Cancer Care Can Help Reduce Disparities, NCCN’s Schatz Says

 

Dr Debra Patt Highlights Payer, Education Considerations in Use of Trastuzumab Deruxtecan for HER2-Low Breast Cancer

Dr Joseph Alvarnas Explains Barriers to Clinical Trial Diversity and Payer Participation

Access Video Interviews from PCOC
Read the PCOC Recap Issue

This site uses cookies. Find out more about cookies and how you can refuse them.

I Accept